Search

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

… Thursday, September 28, 2023 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Michel Sadelain, MD, PhD, Michel Sadelain Awarded 2024 Breakthrough Prize in Life Sciences Michel Sadelain, MD, PhD, renowned physician-scientist, Director of the Center for

Researchers from Memorial Sloan Kettering Cancer Center have begun testing for three new genetic targets and found that together they occur in approximately 50 percent of patients with squamous cell carcinomas of the lung, which affects 40,000 Americans each year. Initial findings of the research will be presented on June 4 at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting.

… Wednesday, May 16, 2012 Screening lung cancer tumor samples for cancer-causing, or “driver,” genetic mutations can help physicians tailor patients’ treatments to target those specific mutations. While scientists have identified cancer-causing mutations for the majority of lung adenocarcinomas — the most

The certification comes after a year in which hundreds of experts worked together to assess standards of care at Hartford HealthCare Cancer Institute.

… Thursday, September 18, 2014 Summary The certification comes after a year in which hundreds of experts worked together to assess standards of care at Hartford HealthCare Cancer Institute. On Tuesday, more than 40 Memorial Sloan Kettering doctors, including President and CEO Craig B. Thompson and Physician-in-Chief

Cancer biologist Andrea Ventura is the incumbent of a Geoffrey Beene Junior Faculty Chair at the Sloan Kettering Institute, he devotes his research to the nascent field of microRNA expression, seeking to understand how these small RNAs act on genes to promote or suppress cancer.

… Monday, February 1, 2010 Summary Cancer biologist Andrea Ventura is the incumbent of a Geoffrey Beene Junior Faculty Chair at the Sloan Kettering Institute, he devotes his research to the nascent field of microRNA expression, seeking to understand how these small RNAs act on genes to promote or suppress

Memorial Sloan Kettering researchers are investigating the use of tiny particles that behave like sponges to take in drugs and deliver them to tumors.

… Monday, March 10, 2014 Summary Memorial Sloan Kettering researchers are investigating the use of tiny particles that behave like sponges to take in drugs and deliver them to tumors. Memorial Sloan Kettering researchers have shown that tiny particles can be manipulated to act like sponges, taking in drugs

MSK researchers are developing a new image-generation method for PET scans. It may prove to be quicker and clearer than current scans.

… Friday, April 19, 2019 Summary MSK researchers are using computer algorithms and artificial intelligence to develop a new type of PET imaging. Recently, the first-ever image of a black hole was splashed across front pages and filled up news feeds around the world. The image was made in part thanks to

Read about new targets and tactics for treating acute myeloid leukemia.

… Monday, June 10, 2024 Ever since he was in college, Michael Rosensweig has endured a series of grueling treatments for acute myeloid leukemia (AML) . This kind of blood cancer is relentless. It moves quickly and needs aggressive, often harsh, treatment with chemotherapy , sometimes followed by a bone

Learn how the Head and Neck Cancer Service at MSK helps people overcome a variety of cancers while preserving facial appearance and function.

… Thursday, September 11, 2025 James Mangan is a world-class rowing coach who has led elite teams in his native Ireland and in the United States all the way to the Olympics. So when he learned he had a serious skin cancer, he was concerned not only for his health but for his ability to continue the work

How does being lesbian, gay, bisexual, or transgender affect your risk of getting cancer? Good question.

… Friday, February 19, 2016 Summary A new policy paper authored by MSK clinicians and patient advocates draws attention to the need for collecting comprehensive data to understand how cancer affects lesbian, gay, bisexual, and transgender people. Until these data are collected, we won’t know for sure the

The discovery links metabolism to the way cancer stem cells form tumors.

… Tuesday, May 26, 2020 Summary A team of scientists at the Sloan Kettering Institute and The Rockefeller University has discovered that cancer stem cells rely on a steady external supply of the amino acid serine. This dependency makes them vulnerable to restrictions on this supply, a discovery that could